Bucolome is a CYP2C9 inhibitor, used as an uricosuric agent or anti-inflammatory agent.
ChEBI: 5-butyl-1-cyclohexylbarbituric acid is a member of barbiturates.
[1] Takahashi H, et al. Pharmacokinetic interaction between warfarin and a uricosuric agent, bucolome: application of In vitro approaches to predicting In vivo reduction of (S)-warfarin clearance. Drug Metab Dispos. 1999 Oct;27(10):1179-86. PMID:10497145
